Insilico Medicine Included in Hong Kong Stock Exchange Tech 100 Index, AI Industry Opportunities Gain Attention
September 3, 2026Insilico Medicine, a clinical-stage drug development technology company driven by generative artificial intelligence (AI), has announced its inclusion in the Hong Kong Stock Exchange Tech 100 Index. The index changes will take effect after the market closes on September 11, 2026, with the new components becoming effective from September 14, 2026.…
Original URL: Click here to visit original article